The Melville-based company, a distributor of branded and private-label products for dentist and physician offices, said ...

Henry Schein (HSIC) stock is in focus after the company secured exclusive U.S. distribution rights for CytoChip’s FDA-cleared ...

Henry Schein currently has a broad portfolio with over $3bn in corporate and owned brand products and services.

The Melville, New York-based company’s soon-to-be new CEO succeeds Stanley M. Bergman, who stepped down from the post.

Stanley Bergman has worked at Henry Schein for 45 years, more than 35 of which he spent as CEO, and was due to retire at the ...

Get the live share price of Henry Schein Inc (HSIC), including intraday charts, historical performance, key financials, and ...

Henry Schein has named Federick M. Lowery as its new CEO effective March 2, 2026. He will also join the company’s board of ...

The new CEO will succeed Stanley Bergman, who has led the pharmaceuticals and healthcare products distributor for the past 35 ...

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Henry Schein appoints Frederick Lowery as CEO, succeeding Stanley Bergman to lead growth and strategic initiatives in dental ...